Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals can help keep you healthy in your golden years. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Its trial drug for the treatment of Type 2 Diabetes, which is associated with obesity, provides health benefits similar to calorie restriction without a change in diet. Founded in 2004, the company owns or licenses more than 150 patent applications for sirtuins, a class of enzymes. The activation of sirtuins helps reduce weight gain, as well improve glucose levels and insulin sensitivity. Sirtris filed an IPO in 2007, but was then acquired by GlaxoSmithKline (GSK) the following year.
Contact Details
Office Address
Sirtris Pharmaceuticals, Inc.
200 Technology Square
Cambridge, MA, USA 02139
Phone: (617) 252-6920
Fax: (617) 252-6924
Executives
CEO
Christoph H. Westphal
COO
Garen G. Bohlin